Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 149408, 11 pages
http://dx.doi.org/10.1155/2015/149408
Research Article

17β Estradiol Modulates Perfusion Pressure and Expression of 5-LOX and CYP450 4A in the Isolated Kidney of Metabolic Syndrome Female Rats

1Department of Pathology, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano No. 1, Sección XVI, 14080 Tlalpan, DF, Mexico
2Department of Physiology, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano No. 1, Sección XVI, 14080 Tlalpan, DF, Mexico
3Department of Reproduction Biology, Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Vasco de Quiroga 15, Sección XVI, 14000 Tlalpan, DF, Mexico
4Animal Facility Services and Experimental Surgery, Facultad de Medicina Universidad La Salle, Avenue De las Fuentes 17, 14000 Tlalpan, DF, Mexico

Received 16 April 2015; Revised 18 May 2015; Accepted 30 May 2015

Academic Editor: Roshanak Rahimian

Copyright © 2015 A. M. Zúñiga-Muñoz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Parikh and M. V. Mohan, “Changing definitions of metabolic syndrome,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 1, pp. 7–12, 2012. View at Publisher · View at Google Scholar
  2. S. M. Grundy, “Metabolic syndrome pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Segura, C. Campo, C. Roldán et al., “Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances,” Journal of the American Society of Nephrology, vol. 15, no. 1, pp. S37–S42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Pérez-Torres, M. El Hafidi, N. Pavón, O. Infante, M. C. Avila-Casado, and G. Baños, “Effect of gonadectomy on the metabolism of arachidonic acid in isolated kidney of a rat model of metabolic syndrome,” Metabolism: Clinical and Experimental, vol. 59, no. 3, pp. 414–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. M. Fischer and M. L. Swain, “Effect of sex hormones on blood pressure and vascular connective tissue in castrated and non castrated male rats,” The American Journal of Physiology, vol. 232, no. 6, pp. H617–H621, 1977. View at Google Scholar · View at Scopus
  6. I. Pérez-Torres, P. Roque, M. El Hafidi, E. Diaz-Diaz, and G. Baños, “Association of renal damage and oxidative stress in a rat model of metabolic syndrome. Influence of gender,” Free Radical Research, vol. 43, no. 8, pp. 761–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Dixon and C. Maric, “17β-estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-β protein expression and signaling,” American Journal of Physiology—Renal Physiology, vol. 293, no. 5, pp. F1678–F1690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Mason and N. A. Wahab, “Extracellular matrix metabolism in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1358–1373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. C. Duncan, J. R. Petrie, M. J. Brosnan et al., “Is estradiol cardioprotection a nitric oxide-mediated effect?” Human Reproduction, vol. 17, no. 7, pp. 1918–1924, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Node, M. Kitakase, H. Kosaka et al., “Roles of NO and Ca2+-activated K+ channels in coronary vasodilation induced by 17beta-estradiol in ischemic heart failure,” The FASEB Journal, vol. 11, no. 10, pp. 793–799, 1997. View at Google Scholar
  11. M. Rosselli, B. Imthurm, E. Macas, P. J. Keller, and R. K. Dubey, “Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release,” Biochemical and Biophysical Research Communications, vol. 202, no. 3, pp. 1543–1552, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Busserolles, A. Mazur, E. Gueux, E. Rock, and Y. Rayssiguier, “Metabolic syndrome in the rat: females are protected against the pro-oxidant effect of a high sucrose diet,” Experimental Biology and Medicine, vol. 227, no. 9, pp. 837–842, 2002. View at Google Scholar · View at Scopus
  13. C.-M. Hao and M. D. Breyer, “Physiologic and pathophysiologic roles of lipid mediators in the kidney,” Kidney International, vol. 71, no. 11, pp. 1105–1115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Marcantoni, L. Di Francesco, L. Totani et al., “Effects of estrogen on endothelial prostanoid production and cyclooxygenase-2 and heme oxygenase-1 expression,” Prostaglandins and Other Lipid Mediators, vol. 98, no. 3-4, pp. 122–128, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. Reaven and H. Ho, “Sugar-induced hypertension in Sprague-Dawley rats,” American Journal of Hypertension, vol. 4, no. 7, pp. 610–614, 1991. View at Google Scholar · View at Scopus
  16. G. Baños, K. Carvajal, G. Cardoso, J. Zamora, and M. Franco, “Vascular reactivity and effect of serum in a rat model of hypertriglyceridemia and hypertension,” American Journal of Hypertension, vol. 10, no. 4, part 1, pp. 379–388, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Bańos, O. N. Medina-Campos, P. D. Maldonado et al., “Activities of antioxidant enzymes in two stages of pathology development in sucrose-fed rats,” Canadian Journal of Physiology and Pharmacology, vol. 83, no. 3, pp. 278–286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. F. Kohn and C. B. Clifford, “Biology and diseases of rats,” in Laboratory Animal Medicine, pp. 121–158, Elsevier Science, New York, NY, USA, 2nd edition, 2002. View at Google Scholar
  19. E. BenGershom, “Screening for albuminuria: a case for estimation of albumin in urine,” Clinical Chemistry, vol. 21, no. 12, pp. 1795–1798, 1975. View at Google Scholar · View at Scopus
  20. R. D. Perrone, N. E. Madias, and A. S. Levey, “Serum creatinine as an index of renal function: new insights into old concepts,” Clinical Chemistry, vol. 38, no. 10, pp. 1933–1953, 1992. View at Google Scholar · View at Scopus
  21. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  23. J. Folch, M. Lees, and G. H. Sloane-Stanley, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  24. J.-Q. Chen, T. R. Brown, and J. Russo, “Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors,” Biochimica et Biophysica Acta, vol. 1793, no. 7, pp. 1128–1143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. N. Wade and J. B. Powers, “Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters,” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 265, no. 3, pp. R559–R562, 1993. View at Google Scholar · View at Scopus
  26. A. J. Bhatia and G. N. Wade, “Energy balance in pregnant hamsters: a role for voluntary exercise?” The American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 265, part 2, no. 3, pp. R563–R567, 1993. View at Google Scholar · View at Scopus
  27. R. E. Stubbins, K. Najjar, V. B. Holcomb, J. Hong, and N. P. Núñez, “Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance,” Diabetes, Obesity & Metabolism, vol. 14, no. 1, pp. 58–66, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Gao, G. Mezei, Y. Nie et al., “Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals,” Nature Medicine, vol. 13, no. 1, pp. 89–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Pérez-Torres, B. Ibarra, E. Soria-Castro et al., “Effect of Glycine on the cyclooxygenase pathway of the kidney arachidonic acid metabolism in a rat model of metabolic syndrome,” Canadian Journal of Physiology and Pharmacology, vol. 89, no. 12, pp. 899–910, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. C. Guerra, A. Zuñiga-Muñoz, V. Guarner Lans, E. Díaz-Díaz, C. A. Tena Betancourt, and I. Pérez-Torres, “Modulation of the activities of catalase, cu-zn, mn superoxide dismutase, and glutathione peroxidase in adipocyte from ovariectomised female rats with metabolic syndrome,” International Journal of Endocrinology, vol. 2014, Article ID 175080, 10 pages, 2014. View at Publisher · View at Google Scholar
  31. I. Pérez-Torres and G. Baños de MacCarthy, “Sex hormone receptors in metabolic syndrome,” in Sex Hormones: Development, Regulation and Disorders, vol. 1, chapter 3, pp. 53–74, Nova Science Publishers, 2011. View at Google Scholar
  32. R. D. Buñag, T. Tomita, and S. Sasaki, “Chronic sucrose ingestion induces mild hypertension and tachycardia in rats,” Hypertension, vol. 5, no. 2, pp. 218–225, 1983. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Guarner-Lans, M. E. Rubio-Ruiz, I. Pérez-Torres, and G. Baños de MacCarthy, “Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease,” Experimental Gerontology, vol. 46, no. 7, pp. 517–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Mendizábal, S. Llorens, and E. Nava, “Hypertension in metabolic syndrome: vascular pathophysiology,” International Journal of Hypertension, vol. 2013, Article ID 230868, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. B. Hoffmamm, Sex Homones; Development, Regulation and Disorders, Endocrinology Research and Clinical Developments, Nova Science, New York, NY, USA, 2011.
  36. A. Dey, R. S. Williams, D. M. Pollock et al., “Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria,” Obesity Research, vol. 12, no. 8, pp. 1278–1289, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Pérez-Torres, V. Guarner, M. El Hafidi, and G. Baños, “Sex hormones, metabolic syndrome and kidney,” Current Topics in Medicinal Chemistry, vol. 11, no. 13, pp. 1694–1705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. C. S. Lemos, C. A. Mandarim-de-Lacerda, D. Dorigo, T. M. Coimbra, and R. Bregman, “Chronic renal failure in male and female rats,” Journal of Nephrology, vol. 18, no. 4, pp. 368–373, 2005. View at Google Scholar · View at Scopus
  39. M. Murakami, S. Shimbara, T. Kambe et al., “The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release: type IIA and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2,” The Journal of Biological Chemistry, vol. 273, no. 23, pp. 14411–14423, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Di, J. A. Sullivan, H. L. Rupnow, R. R. Magness, and I. M. Bird, “Pregnancy induces expression of cPLA2 in ovine uterine artery but not systemic artery endothelium,” Journal of the Society for Gynecologic Investigation, vol. 6, no. 6, pp. 301–306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. J. A. Ospina, D. N. Krause, and S. P. Duckles, “17β-estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase,” Stroke, vol. 33, no. 2, pp. 600–605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Chawengsub, K. M. Gauthier, and W. B. Campbell, “Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 2, pp. H495–H507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Kamata, M. Hosokawa, T. Matsumoto, and T. Kobayashi, “Altered arachidonic acid-mediated responses in the perfused kidney of the streptozotocin-induced diabetic rat,” Journal of Smooth Muscle Research, vol. 42, no. 5, pp. 171–187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Matsuyama, T. Nakatani, T. Hase et al., “The expression of cyclooxygenases and lipoxygenases in renal ischemia-reperfusion injury,” Transplantation Proceedings, vol. 36, no. 7, pp. 1939–1942, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. V. R. Holla, F. Adas, J. D. Imig et al., “Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5211–5216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Minuz, H. Jiang, C. Fava et al., “Altered release of cytochrome P450 metabolites of arachidonic acid in renovascular disease,” Hypertension, vol. 51, no. 5, pp. 1379–1385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Pergola, G. Dodt, A. Rossi et al., “ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 50, pp. 19881–19886, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. K. Cheng, J. C. McGiff, and M. A. Carroll, “Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase,” The American Journal of Physiology—Renal Physiology, vol. 284, no. 3, pp. F474–F479, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Akarasereenont, K. Techatraisak, A. Thaworn, and S. Chotewuttakorn, “The induction of cyclooxygenase-2 by 17β-estradiol in endothelial cells is mediated through protein kinase C,” Inflammation Research, vol. 49, no. 9, pp. 460–465, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Yang, C. Liu, J. Jiang et al., “Ginger extract diminishes chronic fructose consumption-induced kidney injury through suppression of renal overexpression of proinflammatory cytokines in rats,” BMC Complementary and Alternative Medicine, vol. 14, article 174, 12 pages, 2014. View at Publisher · View at Google Scholar
  51. A. Cignarella, M. Kratz, and C. Bolego, “Emerging role of estrogen in the control of cardiometabolic disease,” Trends in Pharmacological Sciences, vol. 31, no. 4, pp. 183–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. D. Imig, “Eicosanoids and renal damage in cardiometabolic syndrome,” Expert Opinion on Drug Metabolism and Toxicology, vol. 4, no. 2, pp. 165–174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. R. A. Zeiss, R. L. Delmonico, A. M. Zeiss, and L. Dornbrand, “Psychologic disorder and sexual dysfunction in elders,” Clinics in Geriatric Medicine, vol. 7, no. 1, pp. 133–151, 1991. View at Google Scholar · View at Scopus
  54. C.-H. Chen, C. Booth-LaForce, H. Park, and S.-Y. Wang, “A comparative study of menopausal hot flashes and their psychosocial correlates in Taiwan and the United States,” Maturitas, vol. 67, no. 2, pp. 171–177, 2010. View at Publisher · View at Google Scholar · View at Scopus